Table 2.
Researcher roles and characteristics | Number | Percentage |
---|---|---|
Role(s) of the researcher | ||
Obtaining informed consent | 116 | 48.1 |
Collection of clinical/phenotypic data and biospecimens | 131 | 54.4 |
Generating genomic data | 164 | 68.0 |
Analysis of genomic data | 218 | 90.5 |
Receiving deidentified samples/data | 194 | 80.5 |
Providing clinical care | 14 | 5.8 |
| ||
Years of experience in human genetic research | ||
<1 year | 4 | 2.3 |
1–5 years | 54 | 30.5 |
6–10 years | 42 | 23.7 |
11–20 years | 48 | 27.1 |
>20 years | 29 | 16.4 |
| ||
Populations studied | ||
Adults | 228 | 94.6 |
Children | 137 | 56.8 |
Fetuses | 20 | 8.3 |
Adults lacking decision-making capacity | 41 | 17.0 |
Terminally ill | 72 | 29.9 |
| ||
Number of participants enrolled | ||
≤100 | 29 | 16.3 |
101–500 | 29 | 16.3 |
501–1,000 | 20 | 11.2 |
1,001–5,000 | 66 | 37.1 |
5,001–10,000 | 15 | 8.4 |
>10,000 | 19 | 10.7 |
| ||
Genetic methods used | ||
Candidate gene resequencing | 176 | 73.0 |
CNV analysis | 164 | 68.0 |
GWAS | 164 | 68.0 |
WES | 178 | 73.9 |
WGS | 132 | 54.8 |
WES and WGS | 112 | 46.5 |
Plans to do WES/WGS | 35 | 14.5 |
| ||
Participants studied using WES or WGS | ||
<10 | 25 | 12.3 |
11–50 | 41 | 20.1 |
51–100 | 32 | 15.7 |
101–500 | 54 | 26.5 |
501–1,000 | 20 | 9.8 |
>1,000 | 32 | 13.3 |
CNV, copy-number variant; GWAS, genome-wide association study; WES, whole-exome sequencing; WGS, whole-genome sequencing.